Immune rebalancing at the maternal-fetal interface of maternal SARS-CoV-2 infection during early pregnancy

Chenxiang Xi,Zihui Yan,Dandan Bai,Yalin Zhang,Beiying Wang,Xiaoxiao Han,Li Wu,Xiaohui Shi,Zhiyi Hu,Ming Tang,Zhongqu Su,Yingdong Liu,Binya Liu,Jiqing Yin,Hong Wang,Xiaocui Li,Yanping Zhang,Shaorong Gao,Wenqiang Liu

DOI: https://doi.org/10.1093/procel/pwae006

2024-03-05

Protein & Cell

Abstract:Abstract The current coronavirus disease 2019 (COVID-19) pandemic caused by severe acute respiratory syndrome coronavirus (SARS-CoV-2) remains a threat to pregnant women. However, the impact of early pregnancy SARS-CoV-2 infection on the maternal-fetal interface remains poorly understood. Here, we present a comprehensive analysis of single-cell transcriptomics and metabolomics in placental samples infected with SARS-CoV-2 during early pregnancy. Compared to control placentas, SARS-CoV-2 infection elicited immune responses at the maternal-fetal interface and induced metabolic alterations in amino acid and phospholipid profiles during the initial weeks post-infection. However, subsequent immune cell activation and heightened immune tolerance in trophoblast cells established a novel dynamic equilibrium that mitigated the impact on the maternal-fetal interface. Notably, the immune response and metabolic alterations at the maternal-fetal interface exhibited a gradual decline during the second trimester. Our study underscores the adaptive immune tolerance mechanisms and establishment of immunological balance during the first two trimesters following maternal SARS-CoV-2 infection.

cell biology

What problem does this paper attempt to address?

The problem that this paper attempts to solve is to explore the impact of maternal SARS - CoV - 2 infection during early pregnancy on the maternal - fetal interface. Specifically, through single - cell transcriptomics and metabolomics analysis, the researchers aim to comprehensively understand how SARS - CoV - 2 infection affects the immune response and metabolic changes at the maternal - fetal interface, and how these changes gradually subside during the development from early to mid - pregnancy.

### Research Background
Although the COVID - 19 pandemic caused by severe acute respiratory syndrome coronavirus 2 (SARS - CoV - 2) has been alleviated to some extent, it still remains an ongoing global challenge and has a significant impact on maternal and infant health. Previous studies have shown that SARS - CoV - 2 infection during pregnancy is associated with fetal complications, such as miscarriage, intrauterine growth restriction, and premature birth. However, there are currently few studies on the specific impact of SARS - CoV - 2 infection in early pregnancy on the maternal - fetal interface.

### Research Objectives
The main objectives of this study are:
1. **Evaluate the impact of SARS - CoV - 2 infection on the immune response at the maternal - fetal interface**: Through single - cell transcriptomics analysis, study the activation of immune cells at the maternal - fetal interface after SARS - CoV - 2 infection and their antiviral responses.
2. **Explore the impact of SARS - CoV - 2 infection on metabolic changes at the maternal - fetal interface**: Through metabolomics analysis, study the changes in amino acid and phospholipid metabolic profiles after infection.
3. **Analyze the dynamic balance of the immune tolerance mechanism**: Study the establishment and maintenance of the immune tolerance mechanism at the maternal - fetal interface after infection, especially during the development from early to mid - pregnancy.
4. **Evaluate the long - term impact of SARS - CoV - 2 infection**: Explore whether the immune and metabolic changes after infection gradually subside during mid - pregnancy, and the potential impact of these changes on fetal development.

### Main Findings
1. **SARS - CoV - 2 infection in early pregnancy causes a wide range of antiviral responses**: The study found that immune cells and trophoblast cells at the maternal - fetal interface showed significant gene expression changes after infection, especially the up - regulation of the expression of interferon - induced transmembrane protein (IFITM) family members.
2. **Limited activation of immune cells**: Although the activation of immune cells was observed, the proportion of macrophages and the expression of major histocompatibility complex class II molecules did not increase significantly, indicating that the immune response was limited.
3. **Enhanced immune tolerance of trophoblast cells**: After infection, the expression of HLA - G in trophoblast cells was up - regulated, enhancing the immune tolerance at the maternal - fetal interface and preventing the occurrence of cytokine storm.
4. **The long - term impact of infection gradually weakens**: As pregnancy progresses, the impact of SARS - CoV - 2 infection on the maternal - fetal interface gradually weakens, and the immune and metabolic changes tend to be normal.

### Conclusion
This study reveals the complex impact of SARS - CoV - 2 infection on the maternal - fetal interface during early pregnancy, including the activation of the immune response and the establishment of the immune tolerance mechanism. These findings contribute to a better understanding of the impact of SARS - CoV - 2 infection on maternal and infant health and provide a scientific basis for future clinical interventions.